13F-HR Filing

Company

REGENERON PHARMACEUTICALS, INC.

Filed

February 6, 2026

Period of Report

December 31, 2025

Accession Number

0001104659-26-011601

A 13F is a quarterly report filed by institutional investment managers with over $100M in assets, disclosing their equity holdings. Learn more about 13F-HR filings →